Sign in
CompletedNo phase

Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.

Key facts

Who runs it
Santen SAS
Where
Denmark, France, Germany, Italy, Spain, Sweden, and United Kingdom10 sites in 7 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
344 people enrolled
Started
29 Jul 2025
Ended
17 Apr 2026
Type of study
Observational, 2 groups
Record updated
22 May 2026

Who can take part

Age
5 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their spherical equivalent (SER): Low myopia is from -0.5 D (inclusive) to -3.0 D (inclusive), Moderate myopia is from -3.0 D to -6.0 D (inclusive) and High myopia is <-6.0 D
  • Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment
  • Patients where myopia is a known or likely contributing factor to the complication

Who cannot take part

  • Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded
  • Parents (or other proxy) of children aged 4 years and below

This trial has no sites in United States.

It has sites in 7 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to assess the impact of myopia in childhood and its long-term complications in adulthood on health-related Quality of Life (HRQoL), providing valuable data for cost-effectiveness models. It will gather country-specific information on healthcare resource utilization, including treatment costs, access to care, and reimbursement policies. In addition, the study will examine how myopia and its treatments affect daily activities and evaluate treatment satisfaction. No data on the efficacy of myopia treatments is collected in this study, and neither is the occurrence of adverse events.

The 2 groups in the trial

  • Childhood Myopia

    Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their refractive error;

  • Adulthood Myopia + Long-Term Complication

    Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Non-interventional Study to Assess the Impact of Myopia in Childhood and the Long-Term Complications in Adulthood on Health-Related Quality of Life (HRQoL).
Record updated
22 May 2026